Sarepta Therapeutics
SRPT
#1490
Rank
$11.94 B
Marketcap
$125.02
Share price
-0.30%
Change (1 day)
42.54%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

EPS for Sarepta Therapeutics (SRPT)

EPS in 2023 (TTM): -$7.83

According to Sarepta Therapeutics 's latest financial reports the company's current EPS (TTM) is -$7.83. In 2022 the company made an earnings per share (EPS) of -$8.03 a decrease over its 2021 EPS that were of -$5.15.

EPS history for Sarepta Therapeutics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.83-2.49%
2022-$8.0355.92%
2021-$5.15-27.16%
2020-$7.07-26.96%
2019-$9.6878.6%
2018-$5.42603.9%
2017-$0.77-85.9%
2016-$5.465.2%
2015-$5.1953.1%
2014-$3.39-0%
2013-$3.39-33.79%
2012-$5.127214.29%
2011-$0.07000-96.11%
2010-$1.8015.38%
2009-$1.56-23.53%
2008-$2.04-37.04%
2007-$3.24-0%
2006-$3.2445.95%
2005-$2.22-46.38%
2004-$4.1440.82%
2003-$2.94-57.02%
2002-$6.84-2.56%
2001-$7.02138.78%
2000-$2.94-20.97%
1999-$3.72-72.2%
1998-$13.38519.44%
1997-$2.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$4.39-156.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.19-8.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.10-60.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.25-84.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.11-47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.65 10.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.27-32.69%๐Ÿ‡บ๐Ÿ‡ธ USA